These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38441776)

  • 1. Liraglutide Improves PCOS Symptoms in Rats by Targeting FDX1.
    Ji S; Yang H; Ji Y; Wu W; Dong Y; Fu H; Tang N; Hou Z; Wang F
    Reprod Sci; 2024 Jul; 31(7):2049-2058. PubMed ID: 38441776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats.
    Wu LM; Wang YX; Zhan Y; Liu AH; Wang YX; Shen HF; Wang YF; Wang LY; Tao ZB; Wang YQ
    Peptides; 2021 Nov; 145():170624. PubMed ID: 34375684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and exenatide upregulate hepatocyte nuclear factor-4α, sex hormone binding globulin levels and improve hepatic triglyceride deposition in polycystic ovary syndrome with insulin resistance rats.
    Xing C; Lv B; Zhao H; Wang D; Li X; He B
    J Steroid Biochem Mol Biol; 2021 Nov; 214():105992. PubMed ID: 34478829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome.
    Hoang V; Bi J; Mohankumar SM; Vyas AK
    PLoS One; 2015; 10(5):e0126119. PubMed ID: 26010091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway.
    Zhang S; Tu H; Yao J; Le J; Jiang Z; Tang Q; Zhang R; Huo P; Lei X
    Reprod Biol Endocrinol; 2020 Jun; 18(1):58. PubMed ID: 32493421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model.
    He Y; Li X; Li Y; Kuai D; Zhang H; Wang Y; Tian W
    Steroids; 2024 Jun; 206():109424. PubMed ID: 38642598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Amelioration of Letrozole-induced Polycystic Ovary Syndrome in Rats: A Therapeutic Approach with Apple Cider Vinegar and Metformin Combination.
    Danduga RCSR; Kurapati AS; Shaik RA; Kola PK; Konidala SK; Varada HB
    Reprod Sci; 2024 Sep; 31(9):2861-2876. PubMed ID: 38777948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats.
    Jahan S; Munir F; Razak S; Mehboob A; Ain QU; Ullah H; Afsar T; Shaheen G; Almajwal A
    J Ovarian Res; 2016 Dec; 9(1):86. PubMed ID: 27923406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the therapeutic potential of moxibustion on polycystic ovary syndrome: a rat model study on gut microbiota and metabolite interaction.
    Lin Y; Zeng H; Lin J; Peng Y; Que X; Wang L; Chen L; Bai N
    Front Cell Infect Microbiol; 2024; 14():1328741. PubMed ID: 38665877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteolin alleviates polycystic ovary syndrome in rats by resolving insulin resistance and oxidative stress.
    Huang Y; Zhang X
    Am J Physiol Endocrinol Metab; 2021 Jun; 320(6):E1085-E1092. PubMed ID: 33900851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paeoniflorin attenuates DHEA-induced polycystic ovary syndrome via inactivation of TGF-β1/Smads signaling pathway
    Zhou J; Tan Y; Wang X; Zhu M
    Aging (Albany NY); 2021 Feb; 13(5):7084-7095. PubMed ID: 33638949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of berberine combined with metformin on autophagy in polycystic ovary syndrome by regulating AMPK/AKT/mTOR pathway.
    Jin R; Chen A; Ye Y; Ren Y; Lu J; Xuan F; Zhou W
    Mol Reprod Dev; 2024 Aug; 91(8):e23768. PubMed ID: 39155689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositide 3-kinase inhibition: A new potential target for the treatment of polycystic ovarian syndrome.
    Shah KN; Patel SS
    Pharm Biol; 2016; 54(6):975-83. PubMed ID: 26459667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of angiopoietin-like protein 2 in ovarian tissue of rat polycystic ovarian syndrome model and its correlation study.
    Wang D; Guo Y; Chai S; Shen K; Li Y; Zhao R
    Reprod Biol Endocrinol; 2020 Sep; 18(1):94. PubMed ID: 32988397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats.
    Jang M; Lee MJ; Lee JM; Bae CS; Kim SH; Ryu JH; Cho IH
    PLoS One; 2014; 9(2):e87623. PubMed ID: 24520334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of SIRT1 in the ovaries of rats with polycystic ovary syndrome before and after therapeutic intervention with exenatide.
    Tao X; Zhang X; Ge SQ; Zhang EH; Zhang B
    Int J Clin Exp Pathol; 2015; 8(7):8276-83. PubMed ID: 26339397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.
    Furat Rencber S; Kurnaz Ozbek S; Eraldemır C; Sezer Z; Kum T; Ceylan S; Guzel E
    J Ovarian Res; 2018 Jun; 11(1):55. PubMed ID: 29958542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide improves follicle development in polycystic ovary syndrome by inhibiting CXCL10 secretion.
    Zhao M; Liao B; Yun C; Qi X; Pang Y
    Reprod Biol Endocrinol; 2024 Aug; 22(1):98. PubMed ID: 39107809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ellagic acid on sex hormones and miRNA-21 expression in rats with polycystic ovary syndrome.
    Khoshvaghti A; Rahbari R
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4263-4273. PubMed ID: 38078918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.